1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. PRIME MEDICINE INC
Prime Medicine Inc
XNAS: PRME
3.43 -0.08 (-2.28%)
1.7M
XNAS Volume

XNAS 10 Apr, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Prime Medicine Inc - PRME - stock price prediction, stock price target, analyst ratings from 13 analysts

Prime Medicine Inc has a share price target of US$ 7, revenue growth forecast of 195.2%, and profit growth estimate of 7.5% for FY26, based on top 13 analyst calls.